These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32025207)

  • 1. Compound C enhances the anticancer effect of aspirin in HER-2-positive breast cancer by regulating lipid metabolism in an AMPK-independent pathway.
    Wu Y; Yan B; Xu W; Guo L; Wang Z; Li G; Hou N; Zhang J; Ling R
    Int J Biol Sci; 2020; 16(4):583-597. PubMed ID: 32025207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delphinidin induced protective autophagy via mTOR pathway suppression and AMPK pathway activation in HER-2 positive breast cancer cells.
    Chen J; Zhu Y; Zhang W; Peng X; Zhou J; Li F; Han B; Liu X; Ou Y; Yu X
    BMC Cancer; 2018 Mar; 18(1):342. PubMed ID: 29587684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
    Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
    Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
    Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle.
    Hadad SM; Hardie DG; Appleyard V; Thompson AM
    Clin Transl Oncol; 2014 Aug; 16(8):746-52. PubMed ID: 24338509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
    Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
    FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells.
    Youn SH; Lee JS; Lee MS; Cha EY; Thuong PT; Kim JR; Chang ES
    Biol Pharm Bull; 2012; 35(1):105-10. PubMed ID: 22223345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer.
    Jhaveri TZ; Woo J; Shang X; Park BH; Gabrielson E
    Oncotarget; 2015 Jun; 6(17):14754-65. PubMed ID: 26143491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK Activation and Metabolic Reprogramming by Tamoxifen through Estrogen Receptor-Independent Mechanisms Suggests New Uses for This Therapeutic Modality in Cancer Treatment.
    Daurio NA; Tuttle SW; Worth AJ; Song EY; Davis JM; Snyder NW; Blair IA; Koumenis C
    Cancer Res; 2016 Jun; 76(11):3295-306. PubMed ID: 27020861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound C sensitizes Caki renal cancer cells to TRAIL-induced apoptosis through reactive oxygen species-mediated down-regulation of c-FLIPL and Mcl-1.
    Jang JH; Lee TJ; Yang ES; Min do S; Kim YH; Kim SH; Choi YH; Park JW; Choi KS; Kwon TK
    Exp Cell Res; 2010 Aug; 316(13):2194-203. PubMed ID: 20451517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin induces unique biological and molecular responses in triple negative breast cancer cells.
    Liu B; Fan Z; Edgerton SM; Deng XS; Alimova IN; Lind SE; Thor AD
    Cell Cycle; 2009 Jul; 8(13):2031-40. PubMed ID: 19440038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathways.
    Guerram M; Jiang ZZ; Yousef BA; Hamdi AM; Hassan HM; Yuan ZQ; Luo HW; Zhu X; Zhang LY
    Oncotarget; 2015 Sep; 6(26):21865-77. PubMed ID: 26068969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade.
    Rivera Rivera A; Castillo-Pichardo L; Gerena Y; Dharmawardhane S
    PLoS One; 2016; 11(6):e0157251. PubMed ID: 27285995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers.
    Guix M; Granja Nde M; Meszoely I; Adkins TB; Wieman BM; Frierson KE; Sanchez V; Sanders ME; Grau AM; Mayer IA; Pestano G; Shyr Y; Muthuswamy S; Calvo B; Krontiras H; Krop IE; Kelley MC; Arteaga CL
    J Clin Oncol; 2008 Feb; 26(6):897-906. PubMed ID: 18180460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling.
    Henry WS; Laszewski T; Tsang T; Beca F; Beck AH; McAllister SS; Toker A
    Cancer Res; 2017 Feb; 77(3):790-801. PubMed ID: 27940576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer Effects of a Korean Herbal Medicine Formula (H9) via AMPK and HER2-PI3K/Akt Signaling in Breast Cancer Cells.
    Lee JH; Son YH; Kwon YW; Park SY; Koo BS; Jung SH
    Phytother Res; 2017 Nov; 31(11):1765-1775. PubMed ID: 28856747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts.
    Chung H; Jung YM; Shin DH; Lee JY; Oh MY; Kim HJ; Jang KS; Jeon SJ; Son KH; Kong G
    Int J Cancer; 2008 Feb; 122(4):816-22. PubMed ID: 17957784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Anticancer Activity of Pterostilbene Against Three Subtypes of Human Breast Cancer Cells.
    Wakimoto R; Ono M; Takeshima M; Higuchi T; Nakano S
    Anticancer Res; 2017 Nov; 37(11):6153-6159. PubMed ID: 29061796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPK-mediated up-regulation of mTORC2 and MCL-1 compromises the anti-cancer effects of aspirin.
    Gao M; Kong Q; Hua H; Yin Y; Wang J; Luo T; Jiang Y
    Oncotarget; 2016 Mar; 7(13):16349-61. PubMed ID: 26918349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytosomal-curcumin antagonizes cell growth and migration, induced by thrombin through AMP-Kinase in breast cancer.
    Hashemzehi M; Behnam-Rassouli R; Hassanian SM; Moradi-Binabaj M; Moradi-Marjaneh R; Rahmani F; Fiuji H; Jamili M; Mirahmadi M; Boromand N; Piran M; Jafari M; Sahebkar A; Avan A; Khazaei M
    J Cell Biochem; 2018 Jul; 119(7):5996-6007. PubMed ID: 29600521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.